Known effects, missing answers, calm questions

The current label cannot fill the gaps

As of September 2026, there is no current FDA-reviewed sermorelin label listing who must avoid it, how often side effects happen, or what use may mean during pregnancy.^note

Warnings from another medicine cannot be copied over and presented as if they were sermorelin's own.

Older studies reported a short list of common problems

In older sermorelin studies, the most often described side effects were brief facial flushing and pain where an injection entered the skin.^note

The children's growth trial reported no harmful changes in routine blood testing.^note

Related drugs raise wider questions

The FDA has warned that medicines which make the body release more growth hormone may cause some of the same harms listed for growth hormone itself. These include higher blood sugar, fluid build-up, and a higher risk of tumours.^note

The FDA wrote that warning about related peptides, not about sermorelin by name, so it does not prove that sermorelin causes those outcomes.

In the studies, researchers checked growth hormone, IGF-1 (a body signal that rises with growth hormone), blood sugar before eating, and blood fats. In one 16-week study of older adults, the only harmful change reported was a rise in blood fats. It had gone away by the end of the study. The studies do not say how much it mattered, so ask the clinician which blood tests are planned and why.^note